Development of Rifampicin Nanoparticles by 32 Factorial Design

DOI:

https://doi.org/10.37285/ijpsn.2010.3.3.6

Authors

  • Gambhire Makarand
  • Vaishali Gambhire
  • Bhalekar Mangesh

Abstract

The preparation and physico-chemical evaluation of rifam-picinloaded poly-(lactic-co-glycolic) acid (PLGA) nanoparticles as per 32 Factorial Design are presented. PLGA (X1) and PVA (Polyvinyl alcohol) solution (X2) as a stabilizing agent were used as independent variables where Particle size (PS) (Y1), Entrapment Efficiency (EE) (Y2) and % Drug Release at 12th h (REL)(Y3) were taken as dependant variables. Rifampicin nanoparticles were prepared by multiple emulsion solvent evaporation method. The results showed the method as reproducible, easy and efficient is the entrapment of drug as well as formation of spherical nanoparticles. Effect of polymer concentration was also evaluated with respect to their % drug entrapment efficiency. The in vitro release studies indicated the rifampicin-loaded PLGA nanoparticles provide sustained drug release over a period of 12h. The optimum batch was R3 which shown particle size 326 nm, 61.70 % EE and 57. 50% drug release at 12th h. Infrared spectroscopy analysis revealed that there was no known chemical interaction between drug and polymer. Hence, this investigation demonstrated the potential of the experimental design in understanding the effect of the formulation variables on the quality of rifampicin nanoparticles.

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Keywords:

Nanoparticles, PLGA, Rifampicin, Factorial design

Downloads

Published

2010-11-30

How to Cite

1.
Makarand G, Gambhire V, Mangesh B. Development of Rifampicin Nanoparticles by 32 Factorial Design. Scopus Indexed [Internet]. 2010 Nov. 30 [cited 2024 Jun. 13];3(3):1085-91. Available from: https://www.ijpsnonline.com/index.php/ijpsn/article/view/521

Issue

Section

Research Articles

References

Park K., Nanotechnology: What it can do for drug delivery, J. Control. Rel., 120:1-3 (2007)

Sinjan De, Dennis Robinson, Polymer relationships during preparation of chitosan–alginate and poly-l-lysine–alginate nanospheres, J.Controlled Release, 89:101-112 (2003).

Gref R, Minamitake, M. T. Peracchia, V. Trubetskoy, V. Torchilin, R. Langer, Biodegradable Long-Circulating Polymeric Nanospheres, Science, 263:1600-1603 (1994).

Alonso M. J., Nanomedicine for overcoming biological barrier, Biomed. Pharmacotheraputics. 58(3):168-172 (2004).

Pandey R. & Khuller G. K. , Nanotechnology based drug delivery system(s) for the management of tuberculosis, Indian J. Exp. Bio, 44:357- 366 (2006).

Dye C., Watt C. J., Bleed D. M., Hosseini S. M., & Raviglione M. C., Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence and deaths globally, JAMA, 293:2767 (2005)

Stetsko G., Statistical experimental design and its application to pharmaceutical development problems. Drug Dev Ind. Pharm., 12:1109-1123 (1986).

Dawoodbhai S., Woodruff C., Rhodes C. T., Optimization of tablet formulations containing talc. Drug Dev Ind Pharm., 17(10):1343-1371 (1991).

Gohel M., Formulation design and optimization of mouth dissolve tablets of nimesulide using vacuum drying technique. AAPS Pharm. Sci. Tech., 5:E36 (2004).

Sammour O. A., Formulation and Optimization of Mouth Dissolve Tablets Containing Rofecoxib Solid Dispersion. AAPS Pharm. Sci. Tech., 7 (2) Article 55 (2006)

Zaghloul A., Faltinek J., Reddy I. K., Khan M.A., Response surface methodology to obtain naproxen controlled release tablets from its microspheres with Eudragit L 100-55. J. Micro-encapsul., 18(5):651-662 (2001).

Pandey R., Zahoor A., Sharma S., Khuller G. K, Nanoparticle encapsulated antitubercular drugs as a potential oral drug delivery system against murine tuberculosis, Tuberculosis, 83:373-378 (2003).

Bolton S., Pharmaceutical Statistics, 3rd ed., Marcel Decker Inc, New York, 326–354 (1990).

Montgomery D. C., Design and Analysis of Experiments, 5th Ed. NY: Wiley & Sons, New York, (2001).

Krishna R. S. M., Shivakumar H. G., Gowda D. V. and Banerjee S., Nanoparticles : A Novel Colloidal Drug Delivery System, Indian J. Pharm. Educ. Res., 40(1):15-21 (2006).

Vyas S. P., Khar R.K, Targeted and Controlled Drug Delivery: Novel Carrier Systems, CBS Publishers, New Delhi, 331-364 (2002).

Musumeci T., Ventura C.A., Giannone I., Ruozi B., Montenegro L., Pignatello R., Puglisi G., PLA/PLGA nanoparticles for sustained release of docetaxel, Int. J. Pharm., 325:172-179 (2006).